A study evaluated the surgical pathology and outcomes of pancreatic metastases from renal cell carcinoma (RCC). The retrospective review included 25 patients who underwent pancreatic surgery, with 24 cases intended for cure. Postoperative complications occurred in 36% of patients, and one patient died during hospitalization. Recurrence was observed in 60% of patients, with a five-year overall survival (OS) rate of 83.6% and disease-free survival (DFS) rate of 32.3%. The median OS after pancreatic resection was 134.8 months, suggesting a favorable prognosis and curative potential of this surgical approach for RCC metastases to the pancreas.
Journal Article by Riemenschneider KA, Farooqui W (…) Hansen CP et 2 al. in Scand J Gastroenterol